Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Glaukos Corp (NY: GKOS )

144.09 +0.09 (+0.06%)
Streaming Delayed Price Updated: 10:31 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corp

< Previous 1 2 3 4 5 6 7 8 Next >
Ivantis To Pay $60M In Patent Litigation Settlement With Glaukos
Glaukos Corp (NYSE:GKOS) has 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Glaukos Announces Settlement of Patent Litigation with Ivantis, Inc.
From Glaukos Corporation
Via Business Wire
Glaukos Files Pre-Market Application For Intraocular Pressure Device
Glaukos Corp (NYSE: GKOS) has submitted a supplemental premarket approval (PMA) application to the FDA for its iStent infinite Trabecular Micro-Bypass System.... 
Via Benzinga
Exposures Product Safety
Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™
From Glaukos Corporation
Via Business Wire
Return on Capital Employed Overview: Glaukos
Pulled from Benzinga Pro data Glaukos (NYSE:GKOS) reported Q2 sales of $78.09 million. Earnings fell to a loss of $14.22 million, resulting in a 20.47% decrease from last quarter... 
Via Benzinga
Why Glaukos Shares Dipped Today
Glaukos (NYSE:GKOS) shares are trading lower after Wells Far... 
Via Benzinga
Glaukos plunges after CMS suggests slashing iStent reimbursement
William Blair downgraded Glaukos following the 
Via Talk Markets
Glaukos Announces Participation in the Wells Fargo Healthcare Conference
From Glaukos Corporation
Via Business Wire
Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies
From Glaukos Corporation
Via Business Wire
Glaukos Guided Below Consensus After Q2 Earnings; Analysts Cut Price Target
Glaukos Corporation (NYSE:GKOS) 
Via Benzinga
Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript
GKOS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Glaukos Corporation Announces Second Quarter 2021 Financial Results
From Glaukos Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021
Upgrades Tudor Pickering upgraded the previous rating for Precision Drilling Corp (NYSE: 
Via Benzinga
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting
From Glaukos Corporation
Via Business Wire
62 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
Via Benzinga
Exposures Product Safety
Why Glaukos Stock Sank Today
An analyst downgraded the healthcare stock. 
Via The Motley Fool
Wells Fargo Downgrades Glaukos To Sell On iStent Reimbursement Cuts
Wells Fargo analyst Lawrence Biegelsen downgraded Glaukos to Underweight from Equal Weight with a price target of $41, down from $100. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
Upgrades For Bank of Marin Bancorp (NASDAQ: 
Via Benzinga
Glaukos Corporation to Release Second Quarter 2021 Financial Results after Market Close on August 5
From Glaukos Corporation
Via Business Wire
55 Biggest Movers From Yesterday
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by... 
Via Benzinga
Mid-Afternoon Market Update: Dow Gains 50 Points; Imara Shares Plunge
Toward the end of trading Wednesday, the Dow traded up 0.15% to 34,942.77 while the NASDAQ rose 0.07% to 14,687.21. The S&P also rose, gaining 0.26% to 4,380.58. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers AcelRx Pharmaceuticals (NASDAQ:ACRX 
Via Benzinga
Mid-Day Market Update: Aspen Group Drops Following Q4 Results; Datasea Shares Surge
Midway through trading Wednesday, the Dow traded up 0.05% to 34,907.35 while the NASDAQ rose 0.48% to 14,747.61. The S&P also rose, gaining 0.24% to 4,379.85. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
34 Stocks Moving In Wednesday's Mid-Day Session
Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution... 
Via Benzinga
Why Glaukos Stock Is Tanking Today
Proposed rates from CMS for fiscal 2022 weren't what investors expected. 
Via The Motley Fool
Mid-Morning Market Update: Markets Open Higher; Citigroup Earnings Beat Expectations
Following the market opening Wednesday, the Dow traded up 0.26% to 34,979.05 while the NASDAQ rose 0.40% to 14,736.66. The S&P also rose, gaining 0.30% to 4,382.38. The U.S.... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 8.98% to $1.94 during Wednesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
William Blair Downgrades Glaukos After Disappointing CMS Rate; Shares Drop
Centers for Medicare and Medicaid Services (CMS) issued its fiscal 2022 proposed physician fee schedule, which included two combined Category I cataract plus stent procedure... 
Via Benzinga
Glaukos Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physician Fee Schedule
From Glaukos Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.